SHAREHOLDER ALERT: WeissLaw LLP Investigates SOC Telemed, Inc.

NEW YORK, Feb. 3, 2022 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of SOC Telemed, Inc. ("SOC Telemed" or the "Company") (NASDAQ: TLMD), in connection with the proposed acquisition of the Company by Patient Square Capital ("Patient Square").  Under the terms of the acquisition agreement, the Company's shareholders will receive $3.00 in cash for each share of SOC Telemed common stock that they hold. 

If you own SOC Telemed shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:

https://www.weisslaw.co/news-and-cases/tlmd
Or please contact:
Joshua Rubin, Esq.
WeissLaw LLP
305 Broadway, 7^th Floor
New York, NY  10007
(212) 682-3025
(888) 593-4771
[email protected]

WeissLaw LLP is investigating whether (i) SOC Telemed's board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction, (ii) the $3.00 per-share merger consideration adequately compensates SOC Telemed's shareholders, and (iii) all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed. 

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at [email protected]

SOURCE WeissLaw LLP